Katharine Bushby Selected Research

Stamulumab

5/2008

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katharine Bushby Research Topics

Disease

3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2019 - 05/2008
2	Muscular Diseases (Myopathy) 10/2014 - 06/2008
1	Insulin Resistance 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2014
1	Rare Diseases (Rare Disease) 08/2014
1	type 2B Limb-girdle muscular dystrophy 06/2008
1	Hypersensitivity (Allergy) 05/2008
1	Muscular Dystrophies (Muscular Dystrophy) 05/2008
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 05/2008

Drug/Important Bio-Agent (IBA)

1	GlucocorticoidsIBA 01/2019
1	VBP15 compoundIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Nonsense Codon (Nonsense Mutation)IBA 10/2014
1	Investigational DrugsIBA 10/2014
1	atalurenIBA 10/2014
1	SolutionsIBA 06/2008
1	Proteins (Proteins, Gene)FDA Link 06/2008
1	DysferlinIBA 06/2008
1	Neutralizing AntibodiesIBA 05/2008
1	MyostatinIBA 05/2008
1	StamulumabIBA 05/2008

Therapy/Procedure

3	Therapeutics 01/2019 - 08/2014